ATI RN
Urinary System Multiple Choice Questions Questions
Question 1 of 5
Intraoperative consultation is called by a gynaecologist for possible urinary tract injury during a difficult transabdominal hysterectomy. During inspection clear fluid is noted in the pelvis with ureteral transection on left side. What is the next step?
Correct Answer: A
Rationale: Ureteroureterostomy with DJ stent repairs ureteral transection excises damaged ends, anastomoses, and stents for healing, addressing clear fluid (urine). Observation risks leak/fistula unacceptable. Stent alone won't fix complete cut temporary. Cutaneous ureterostomy is last resort avoidable here. Immediate repair distinguishes it, critical for restoring continuity, unlike passive or palliative options.
Question 2 of 5
HIVEC' is a newer technique used in the treatment of
Correct Answer: B
Rationale: HIVEC (Hyperthermic Intra-VEsical Chemotherapy) delivers heated chemo (e.g., mitomycin) to bladder targets non-muscle-invasive cancer. Renal cell uses systemic therapy wrong site. Prostate employs radiation/surgery not intravesical. Penile cancer is surgical topical rare. Bladder-specific HIVEC distinguishes it, critical for enhancing chemo efficacy, unlike systemic or external treatments.
Question 3 of 5
All of the following drugs are immune checkpoint inhibitors for treatment of metastatic renal cell carcinoma, Except:
Correct Answer: A
Rationale: Bevacizumab is a VEGF inhibitor blocks angiogenesis, not an immune checkpoint inhibitor (e.g., PD-1/CTLA-4). Pembrolizumab, Ipilimumab, and Nivolumab target immunity enhance T-cell response in metastatic RCC. Bevacizumab's vascular mechanism distinguishes it, critical for differentiating therapies, unlike immune-boosting drugs.
Question 4 of 5
All of the following are indications of induction chemotherapy in carcinoma penis, except
Correct Answer: B
Rationale: >4 mobile lymph nodes isn't a standard induction chemo indication resectable, not advanced. Fixed nodes, >4 cm nodes, and pelvic mets signal unresectable/advanced disease chemo downsizes. Mobile node count lacks size/fixity specificity less urgent. Exclusion of mobile nodes distinguishes it, key to penile cancer staging, unlike high-risk indications.
Question 5 of 5
Which of the following is unlikely to recur in transplant kidney?
Correct Answer: A
Rationale: ADPKD doesn't recur in transplants native cysts remain, new kidney unaffected (genetic, not systemic). Hyperoxaluria type 1 recurs oxalate damages graft. Atypical HUS (complement) can relapse systemic. Glomerulonephritis (e.g., IgA) often returns immune-driven. ADPKD's non-recurrence distinguishes it, critical for transplant prognosis, unlike systemic or immune risks.